Addition of roxadustat to erythropoiesis-stimulating agent (ESA) effectively corrects ESA-hyporesponsive anaemia in patients on peritoneal dialysis

Dai, SQ; Chen, Y; Hao, CM; Ge, XL; Xie, QH; Shang, D; Zhu, TY

Zhu, TY (通讯作者),Fudan Univ, Huashan Hosp, Dept Nephrol, 12 Wulumuqi Rd Middle, Shanghai 200040, Peoples R China.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022; 47 (10): 1525

Abstract

What Is Known and Objective Erythropoiesis-stimulating agent (ESA) hyporesponsiveness is an important cause for the undertreatment of anaemia. A decre......

Full Text Link